Philip Brunell receives the first injection at NIH of the experimental shingles vaccine from nurse Patricia Hohman.
TRIAL VETERAN When Philip Brunell received the first shingles vaccination in a Phase III trial June 17, it was not exactly a shot in the dark. The senior attending physician at the National Institutes of Health clinical center estimates he's been injected in the name of science 20-30 times. "Whenever we've had a vaccine trial and I've been eligible, I've taken the first dose." The National Institute of Allergy and Infectious Diseases trial tests a more potent version of the vaccine used to immunize children against the chicken pox to cause an immune response against varicella-zoster virus (VZV). VZV causes both shingles and chicken pox. The virus remains dormant in nerve...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!